ADN1.DEADN1.DEXETRA
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +14.92% | +11.07% | +12.23% | +13.03% | +13.44% |
| Gross Profit Growth | +17.15% | -2.39% | +62.36% | -18.22% | +1.28% |
| EBITDA Growth | +37.20% | +20.24% | +1.48% | +53.50% | +4.07% |
| Operating Income Growth | +58.46% | +40.24% | +1968.67% | -95.33% | -1.14% |
| Net Income Growth | +95.89% | +100.31% | +0.00% | +0.00% | +10.03% |
| EPS Growth | +96.47% | +101.85% | +0.00% | +0.00% | +11.98% |
| EPS Diluted Growth | +96.47% | +101.85% | +0.00% | +0.00% | +11.98% |
| Weighted Average Shares Growth | +0.00% | -0.17% | -1.25% | -1.83% | -1.78% |
| Weighted Average Shares Diluted Growth | +0.03% | -0.11% | +0.03% | -1.83% | -1.80% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +18.87% | -21.16% | +0.00% | -265.45% | -20.18% |
| Free Cash Flow Growth | +65.11% | -16.64% | +0.00% | +0.00% | -24.24% |
| Receivables Growth | -6.04% | -1.94% | +2.93% | +18.69% | +14.91% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +1.47% | +3.42% | +5.44% | +5.71% | +7.67% |
| Book Value per Share Growth | -0.88% | -6.26% | -6.27% | -3.76% | -3.89% |
| Debt Growth | +4.34% | +0.93% | +8.90% | +6.31% | -0.63% |
| R&D Expense Growth | +0.00% | -67.43% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +2.85% | +70.98% | -100.00% | +0.00% | +0.50% |